Investor Day 2026
Logotype for Kerry Group PLC

Kerry Group (KRZ) Investor Day 2026 summary

Event summary combining transcript, slides, and related documents.

Logotype for Kerry Group PLC

Investor Day 2026 summary

9 Oct, 2026

Strategic position and growth

  • Portfolio transformation completed just under two years ago, creating a pure-play B2B taste and nutrition business; biotechnology, global footprint and retailer go-to-market capabilities expanded.

  • Strategy prioritizes volume growth, EBITDA margin expansion, EPS, cash flow and returns, with innovation and renovation supported by technology, application expertise and integrated solutions.

  • Accelerate 2.0 optimizes the footprint and scales digital initiatives across commercial, R&D, supply chain, manufacturing and business functions.

Market opportunity and customer dynamics

  • Addressable value-add specialty ingredient market is €87bn and projected to exceed €100bn in 5-10 years, primarily driven by renovation.

  • Inflation, affordability pressures, regulation, health and wellness trends and supply-chain disruption prompt reformulation, while customers seek to protect product quality and taste.

  • Customer demand is shifting toward integrated outcomes spanning consumer appeal, labeling, manufacturing and economics; rapid commercialization is increasingly important.

  • FY2025 revenue mix: Americas 55%, APMEA 24%, Europe 21%; food 66%, beverage 27%, pharma and other 7%; developed markets 67%, emerging markets 33%.

Technology, R&D and innovation

  • More than €3bn invested in the science and technology ecosystem over 10 years; 2025 R&D investment was €315m, supporting 1,300+ scientists, 60+ innovation centres, ~400 PhDs and master’s graduates, and 1,200+ patents and applications.

  • R&D investment target is 5-6% of revenue; digital and AI are being applied to commercial, formulation and analytical knowledge.

  • Capabilities combine taste technologies, biotechnology, application expertise and customised solutions; 40% of the taste portfolio is delivered through biotechnology.

  • Five future technology areas each offer potential above €50m: advanced nutrition modulation, fermentation and natural ingredients, resource scarcity solutions, future-proof preservation, and food as a therapeutic.

  • Solutions include sodium and sugar reduction, masking, clean-label and sorbate-free preservation, natural colours, and fermentation-based taste.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more

Latest events from Kerry Group